The Microcap Newsletter
  • Deal Tables
  • News
  • Events
    • The Microcap Conference
    • The SPAC Conference
    • The Reg A Conference
    • The Venture Debt Conference
    • The DTC Healthcare Conference
    • The Healthcare Services
      Investment Conference
  • Free Sign Up
  • Register for The Microcap Conference
Free Sign Up
Attend The Microcap Conference
No Result
View All Result
The Microcap Newsletter
  • Deal Tables
  • News
  • Events
    • The Microcap Conference
    • The SPAC Conference
    • The Reg A Conference
    • The Venture Debt Conference
    • The DTC Healthcare Conference
    • The Healthcare Services
      Investment Conference
  • Free Sign Up
  • Register for The Microcap Conference
Free Sign Up
Attend The Microcap Conference
No Result
View All Result
The Microcap Newsletter
No Result
View All Result

Microcap IPO Flow Trickles Through January

January 22, 2024

The microcap IPO flow trickles through the end of January, with four companies on the calendar.

An expected uptick in February includes tech enterprises.

“Every tech unicorn will need to prove itself by hitting numbers as a public company, and an IPO starts that clock,” said Bill Smith of Renaissance Capital.

Companies on the calendar include a distributor of reflective and non-reflective garment trims, a seller and deliverer of electric light commercial vehicles, a luxury lifestyle brand focused on activewear and ski apparel, and a biotech firm.

Luxury Lifestyles and Extreme Sports

Perfect Moment (PMNT) has an estimated IPO date of Jan. 15, aiming to raise about $16 million at around a $108 million market cap. Founded in 1984 and based in the United Kingdom, the company is a luxury lifestyle brand focused on ski apparel and activewear inspired by the design of Thierry Donald, a professional skier and extreme sports filmmaker.

Perfect Moment booked $24 million in sales for the year ended June 30. The joint bookrunners on this deal are ThinkEquity and Laidlaw & Company.

Biotech Focused on Peptides and Proteins

Biolingus (Cayman) Limited (SUBL) has an estimated IPO date of Jan. 31, intending to raise $7 million at around a $222 million market cap. Founded in 2012 and based in Switzerland, the company is a Phase 1 biotech focused on developing sublingual delivery of peptides and proteins for metabolic diseases such as diabetes, NASH, and others.

Biolingus (Cayman) Limited showed no revenue for the year ended April 30. The sole bookrunner on this deal is Univest Securities.

Updated IPOs

J-Long Group Limited (JL) had estimated IPO dates of Dec. 22, Jan. 12, and Jan. 19, seeking to raise $7 million at a $157 million market cap. Now, the company has an estimated IPO date of Jan. 23, still intending to raise $7 million.

HW Electro (HWEP) had an estimated IPO date of Jan. 7, aiming to raise $15 million at around a $167 million market cap. Now, the company has an estimated IPO date of Jan. 24 and is still seeking to raise $15 million at the same market cap.

Recent Posts

Bi-Monthly Report on SEC Oversight of Penny Stock Violations

SEC: Unregistered Dealer Profits from Distressed Penny-Stock Sales

March 11, 2024
Microcap IPO Flow Remains Strong into September

Microcap IPO Flow Holds Steady into Mid-March

March 11, 2024
Cocrystal Pharma CEO Offers Look at Clinical Development and 2024 Value Catalysts

Cocrystal Pharma CEO Offers Look at Clinical Development and 2024 Value Catalysts

March 11, 2024
DealFlow Events logo

PO Box 122
Syosset, NY 11791
(516) 876-8006
team@dealflowevents.com

Twitter

Subscribe to our free newsletter

Stay informed on the latest weekly Microcap news.

SIGN UP

Sponsored content, this is a paid promotion

Comments and opinions presented in DealFlow Events publications such as The Microcap Newsletter are solely those of the analysts, corporate executives, and others quoted. They do not represent the opinions of DealFlow Events and DealFlow Events makes no recommendations on whether to buy, sell or hold shares of any particular stock. Investors are advised to conduct their own research before making an investment decision. Neither DealFlow Events nor any of its affiliates hold any position in the stocks mentioned in The Microcap Newsletter.

© DealFlow Financial Products, Inc. (d/b/a DealFlow Events). All rights reserved. DealFlow Events™ and The Microcap Conference™ and The Microcap Newsletter™ are trademarks of DealFlow Financial Products, Inc.

  • Deal Tables
  • News
  • Events
    • The Microcap Conference
    • The SPAC Conference
    • The Reg A Conference
    • The Venture Debt Conference
    • The DTC Healthcare Conference
    • The Healthcare Services
      Investment Conference
  • Free Sign Up
  • Register for The Microcap Conference